[1] SHEN T, LIU Y, SHANG J, et al.Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241. [2] Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2015, 31(11): 1752-1769. [3] HE Z, ZHAO Y, GUO C, et al.Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey[J]. Br J Cancer, 2010, 103(7): 1085-1088. [4] GAO Y, FANG WJ, ZHANG YL.Retrospective study of 185 patients with drug-induced liver injury[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2019, 28(7): 439-444. [5] CHEN XQ. New Pharmacology(新编药物学)[M]. Beijing: People’s Medical Publishing House, 2018. [6] AMACHER DE.Female gender as a susceptibility factor for drug-induced liver injury[J]. Hum Exp Toxicol, 2013, 33(9): 928-939. [7] ALHADDAD O, ELSABAAWY M, ABDELSAMEEA E, et al.Presentations, causes and outcomes of drug-induced liver injury in egypt[J]. Sci Rep, 2020, 10(1): 5124-5133. [8] GREWAL P, AHMAD J.Severe liver injury due to herbal and dietary supplements and the role of liver transplantation[J]. World J Gastroenterol, 2019, 25(46): 6704-6712. [9] BJÖRNSSON ES. Hepatotoxicity of statins and other lipid-lowering agents[J]. Liver Int, 2017, 37(2): 173-178. [10] JING J, TESCHKE R.Traditional Chinese medicine and herb-induced liver injury: comparison with drug- induced liver injury[J]. J Clin Transl Hepatol, 2018, 6(1): 57-68. [11] XU CS.Effect of small dose prednisone on orbital inflammatory pseudotumor and its effect on liver function[J]. Chinese Hepatology(肝脏), 2016, 21(10): 901-902. [12] ADAMEC I, PAVLOVIĆ I, PAVIČIĆ T, et al. Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis[J]. Mult Scler Relat Disord, 2018(25): 43-45. [13] BENESIC A, ROTTER I, DRAGOI D, et al.Development and validation of a test to identify drugs that cause idiosyncratic drug-induced liver injury[J]. Clinical Gastroenterology and Hepatology, 2018, 16(9): 1488-1494. [14] CAI RN, XUE HL, REN XD.Pharmaceutical care for one patient with liver injury induced by glycocorticoids[C]. The 13th youth pharmaceutical research exchange meeting of Chinese Pharmaceutical Association, 2016. [15] ZHENG J, ZHENG S, FENG Q, et al. Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications[J]. Biosci Rep, 2017, 37(3): BSR20170286. [16] QIU YL, MA L, ZHU XL, et al.Severe liver injury caused by orlistat[J]. ADRJ(药物不良反应杂志), 2019, 21(3): 231-232. [17] DOUGLAS IJ, LANGHAM J, BHASKARAN K, et al.Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink[J]. BMJ, 2013(346): f1936. [18] U. S. FDA. FDA Drug Safety Communication: completed safety review of Xenical/Alli (orlistat) andsevere liver injury [EB/OL]. (2009-04-24) [2020-06-25]. https://www.fda.gov/drugs/postmarket-drug-safety- informat -ion-patients-and-providers/fda-drug-safety-communication-completed-safety-review-xenicalalli-orlistat-and-severe-liver-injury. [19] European Medicines Agency. European Medicines Agency starts review of orlistat-containing medicines [EB/OL]. (2011-09-22) [2020-06-25]. https://www.ema.europa.eu/en/news/european-medicines- agency-start s-review-orlistat-containing-medicines. [20] National Medical Products Administration. Adverse drug reaction information circular (issue 36) Alert to the risk of serious liver damage caused by orlistat[EB/OL]. (2011-03-04)[2020-06-25]. http://www.nmpa.gov.cn/ WS04/CL 2155/318852.html. [21] JIA WP, GUO DH, TIAN XY, et al.Analysis of 1110 cases of drug-induced liver injury in 79 hospitals[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(8): 481-485. [22] HU PF, XIE WF.Corticosteroid therapy in drug-induced liver injury: pros and cons[J]. J Dig Dis, 2019, 20(3): 122-126. |